Cargando…

Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research

SIMPLE SUMMARY: Synovial sarcoma (SyS) is a rare malignant tumor mainly occurring in children, adolescents, and young adults. SyS displays the pathognomonic t(X;18) translocation resulting in the SS18-SSX fusion protein being able to interact with both the BAF enhancer complexes and polycomb repress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Landuzzi, Lorena, Ruzzi, Francesca, Lollini, Pier-Luigi, Scotlandi, Katia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913760/ https://www.ncbi.nlm.nih.gov/pubmed/36765545 http://dx.doi.org/10.3390/cancers15030588

Ejemplares similares

Innovative Breakthroughs for the Treatment of Advanced and Metastatic Synovial Sarcoma
por: Landuzzi, Lorena, et al.
Publicado: (2023)

Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
por: Nanni, Patrizia, et al.
Publicado: (2019)

Integrated Molecular Characterization of Patient-Derived Models Reveals Therapeutic Strategies for Treating CIC-DUX4 Sarcoma
por: Carrabotta, Marianna, et al.
Publicado: (2022)

Patient Derived Xenografts for Genome-Driven Therapy of Osteosarcoma
por: Landuzzi, Lorena, et al.
Publicado: (2021)

Metformin as an Adjuvant Drug against Pediatric Sarcomas: Hypoxia Limits Therapeutic Effects of the Drug
por: Garofalo, Cecilia, et al.
Publicado: (2013)

Targeting Glutathione-S Transferase Enzymes in Musculoskeletal Sarcomas: A Promising Therapeutic Strategy
por: Pasello, Michela, et al.
Publicado: (2011)

Lamin A and the LINC complex act as potential tumor suppressors in Ewing Sarcoma
por: Chiarini, Francesca, et al.
Publicado: (2022)

IFN-γ and CD38 in Hyperprogressive Cancer Development
por: Angelicola, Stefania, et al.
Publicado: (2021)

Bioprofiling TS/A Murine Mammary Cancer for a Functional Precision Experimental Model
por: De Giovanni, Carla, et al.
Publicado: (2019)

An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas
por: Guerzoni, Clara, et al.
Publicado: (2014)

ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLC
por: Ruzzi, Francesca, et al.
Publicado: (2022)

Cancer Vaccines Co-Targeting HER2/Neu and IGF1R
por: De Giovanni, Carla, et al.
Publicado: (2019)

Cancer immunoprevention: from mice to early clinical trials
por: Palladini, Arianna, et al.
Publicado: (2018)

CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality
por: Sorrentino, Carlo, et al.
Publicado: (2022)

In vitro differentiation of rhabdomyosarcomas induced by nickel or by Moloney murine sarcoma virus.
por: Nanni, P., et al.
Publicado: (1991)

Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma
por: Kawano, Satoshi, et al.
Publicado: (2016)

Preclinical Models of Visceral Sarcomas
por: Costa, Alice, et al.
Publicado: (2023)

Modeling synovial sarcoma metastasis in the mouse: PI3′-lipid signaling and inflammation
por: Barrott, Jared J., et al.
Publicado: (2016)

Preclinical Testing of Erlotinib in a Transgenic Alveolar Rhabdomyosarcoma Mouse Model
por: Abraham, Jinu, et al.
Publicado: (2011)

ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
por: Zucchini, Cinzia, et al.
Publicado: (2019)

Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma
por: Kawano, Satoshi, et al.
Publicado: (2017)

Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
por: Wirths, Oliver, et al.
Publicado: (2020)

The mouse in preclinical trials: transgenic, carcinogen-induced, or xenograph models – which to use?
por: Brown, P
Publicado: (2003)

HER Tyrosine Kinase Family and Rhabdomyosarcoma: Role in Onset and Targeted Therapy
por: De Giovanni, Carla, et al.
Publicado: (2021)

A humanized orthotopic mouse model for preclinical evaluation of immunotherapy in Ewing sarcoma
por: Luo, Wen, et al.
Publicado: (2023)

Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
por: Sanchez-Varo, Raquel, et al.
Publicado: (2022)

Preclinical Imaging for the Study of Mouse Models of Thyroid Cancer
por: Greco, Adelaide, et al.
Publicado: (2017)

Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice
por: Ianzano, Marianna L., et al.
Publicado: (2013)

Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice
por: Boggio, Katia, et al.
Publicado: (1998)

Advances in preclinical therapeutics development using small animal imaging and molecular analyses: the gastrointestinal stromal tumors model
por: Pantaleo, M. A., et al.
Publicado: (2009)

Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression
por: Giusti, Veronica, et al.
Publicado: (2021)

Preclinical Therapy of Disseminated HER-2(+) Ovarian and Breast Carcinomas with a HER-2-Retargeted Oncolytic Herpesvirus
por: Nanni, Patrizia, et al.
Publicado: (2013)

Underlying Ossification Phenotype in a Murine Model of Metastatic Synovial Sarcoma
por: Kirkham, Matthew, et al.
Publicado: (2020)

Preclinical In Vivo Modeling of Pediatric Sarcoma—Promises and Limitations
por: Imle, Roland, et al.
Publicado: (2021)

Mouse models of colorectal cancer as preclinical models
por: McIntyre, Rebecca E., et al.
Publicado: (2015)

Carcinogenesis in transgenic mouse models.
por: Lyon, T
Publicado: (1997)

Transgenic mouse models for ADHD
por: Leo, Damiana, et al.
Publicado: (2013)

Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas
por: Landuzzi, Lorena, et al.
Publicado: (2014)

Extensive splicing changes in an ALS/FTD transgenic mouse model overexpressing cytoplasmic fused in sarcoma
por: Ito, Daisuke, et al.
Publicado: (2020)

Preclinical Models: Boosting Synergies for Improved Translation
por: Attanasio, Chiara, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_amndjmbg3hfmhkfmt4au60e4cp